Patents by Inventor Barbara Olson

Barbara Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRFG-1b, a target and marker for chronic renal failure
    Patent number: 6255471
    Abstract: CRFG-1b polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CRFG-1b polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal disease, renal ischemia, diabetic nephropathy, acute renal failure, neurodegenerative disease, and Alzheimer's disease, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: February 9, 1998
    Date of Patent: July 3, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Nicholas J Laping, Barbara Olson, Yuan Zhu
  • CRFG-1a, a target and marker for chronic renal failure
    Patent number: 6127522
    Abstract: CRFG-1a polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CRFG-1a polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal disease, renal ischemia, diabetic nephropathy, acute renal failure, Neurodegenerative disease, and Alzeimer's disease, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: November 16, 1998
    Date of Patent: October 3, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Nicholas J Laping, Barbara Olson, Yuan Zhu
  • CRFG-1a, a target and marker for chronic renal failure
    Patent number: 5879908
    Abstract: CRFG-1a polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CRFG-1a polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal disease, renal ischemia, diabetic nephropathy, acute renal failure, Neurodegenerative disease, and Alzheimer's disease, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: February 9, 1998
    Date of Patent: March 9, 1999
    Assignee: Smithkline Beecham Corporation
    Inventors: Nicholas J Laping, Barbara Olson, Yuan Zhu